{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T10:39:59Z","timestamp":1793529599356,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000547.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000}}],"reference-count":132,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000547.pub3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:21:29Z","timestamp":1743848489000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preoperative medical therapy before surgery for uterine fibroids"],"prefix":"10.1002","volume":"2025","author":[{"given":"Lucian","family":"Puscasiu","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures; Targu Mures Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Vollenhoven","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Monash University; Clayton Australia"},{"name":"Women's and Newborn Program; Monash Health; Melbourne, Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E","family":"Nagels","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana-Marta","family":"Melinte","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures; Targu Mures Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian G","family":"Showell","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lethaby","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"Suppl","key":"10.1002\/14651858.CD000547.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1471-0528.1994.tb13683.x","article-title":"Deferred versus immediate surgery for uterine fibroids: clinical trial results","volume":"101","author":"Audebert","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD000547.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3109\/00016349509024390","article-title":"Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma","volume":"74","author":"Balasch","year":"1995","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejogrb.2006.07.042","article-title":"A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women","volume":"135","author":"Baytur","year":"2007","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0015-0282(16)58443-X","article-title":"Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study","volume":"66","author":"Benagiano","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0005|cit5","first-page":"317","article-title":"Preoperative treatment of uterine fibroids with low-dose mifepristone: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"56","author":"Bian","year":"2021","journal-title":"Chinese Journal of Obstetrics and Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD000547.pub3-BIB0006|cit6","first-page":"356","article-title":"Pre-operative medical treatment of uterine leiomyomatosis with hypophysiary gonadotropin releasing hormone analogues","volume":"63","author":"Bustos L\u00f3pez","year":"1995","journal-title":"Ginecolog\u00eda y Obstetricia de M\u00e9xico"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0007|cit7","first-page":"263","article-title":"Role of goserelin-depot in the clinical management of uterine fibroids","volume":"21","author":"Cagnacci","year":"1994","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/humrep\/14.1.44","article-title":"Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotropin-releasing hormone analogues","volume":"14","author":"Campo","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0009|cit9","first-page":"102","article-title":"Administration of preoperative gonadotropin releasing hormone agonist (buserelin) for uterine leiomyomas","volume":"4","author":"Cetin","year":"1995","journal-title":"Annals of Medical and Health Sciences Research"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0010|cit10","first-page":"343","article-title":"Short treatment with leuprolide acetate depot before hysterectomy for uterine leiomyomata","volume":"46","author":"D'Anna","year":"1994","journal-title":"Minerva Ginecologica"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2009.02.006","article-title":"Leiomyoma pseudocapsule after presurgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes","volume":"144","author":"De Falco","year":"2009","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/aogs.13713","article-title":"Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): short-term results of a double-blind randomized controlled trial","volume":"99","author":"De Milliano","year":"2019","journal-title":"Acta Obstetrica Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejogrb.2020.06.035","article-title":"Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): long term results of a double-blind randomized controlled trial","volume":"252","author":"De Milliano","year":"2020","journal-title":"European Journal of Obstetrics, Gynecolology and Reproductive Biology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0014|cit14","unstructured":"Ulipristal acetate vs GnRHa prior to laparoscopic myomectomy (MYOMEX) https:\/\/clinicaltrials.gov\/study\/NCT02288130"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0015-0282(03)00261-9","article-title":"A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy","volume":"79","author":"Vivancos","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000547.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomised placebo controlled trial","volume":"24","author":"Engman","year":"2009","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jmig.2017.11.011","article-title":"Intraoperative effect of preoperative gonadotropin-releasing hormone analogue administration in women undergoing cold loop hysteroscopic myomectomy: a randomized controlled trial","volume":"25","author":"Favilli","year":"2017","journal-title":"Journal of Minimally Invasive Gynecology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0020|cit20","unstructured":"GnRH agonist pretreatment in hysteroscopic myomectomy clinicaltrials.gov\/ct2\/show\/NCT01873378"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1471-0528.1990.tb01824.x","article-title":"Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence","volume":"97","author":"Fedele","year":"1990","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0015-0282(16)55164-4","article-title":"Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo","volume":"58","author":"Friedman","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0015-0282(16)61022-1","article-title":"A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy","volume":"52","author":"Friedman","year":"1989","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000184806","article-title":"The place of Zoladex in deferred surgery for uterine fibroids. Zoladex Myoma Study Group","volume":"45","author":"Gerris","year":"1996","journal-title":"Hormone Research"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/oxfordjournals.humrep.a138070","article-title":"Pre-operative gonadotropin-releasing hormone agonist treatment in surgery for uterine leiomyomata","volume":"8","author":"Golan","year":"1993","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0026|cit26","unstructured":"Golan A Bukovsky I Schneider D Pansky M Caspi E Preoperative GnRH-analog treatment in surgery for uterine myomas 3rd International Sympoisum on Gynaecological Endocrinology, Switzerland, 25-28 Feb 1993 1993 15"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0027|cit27","first-page":"109","article-title":"Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women","volume":"77","author":"Hudecek","year":"2012","journal-title":"Ceska Gynekologie"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment","volume":"111","author":"Levens","year":"2008","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1471-0528.1994.tb11919.x","article-title":"Treatment with the gonadotropin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids","volume":"101","author":"Lumsden","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD000547.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/deq188","article-title":"The value of preoperative treatment with GnRH analogues in women with submucous fibroids: a double blind placebo controlled randomised trial","volume":"25","author":"Mavrelos","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"8","key":"10.1002\/14651858.CD000547.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.clinthera.2007.08.024","article-title":"Goserelin acetate 10.8 mg plus iron monotherapy prior to surgery in premenopausal women with iron deficiency anemia due to uterine leiomyomas: results from a phase III, randomized, multicenter, double blind, controlled trial","volume":"29","author":"Muneyyirci-Delale","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.fertnstert.2009.05.070","article-title":"GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomised, multicenter study","volume":"94","author":"Muzii","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0033|cit33","first-page":"38","article-title":"Comparative study on the efficacy of preoperative use of GnRH agonists in patients with uterine fibromyomas","volume":"38","author":"Nikolov","year":"1999","journal-title":"Akuserstvo i Ginekologija"},{"issue":"Suppl","key":"10.1002\/14651858.CD000547.pub3-BIB0034|cit34","first-page":"31","article-title":"Preoperative use of Zoladex for treatment of uterine fibromyomas (abstract)","volume":"76","author":"Nikolov","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9378(94)70332-9","article-title":"The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective randomised study","volume":"170","author":"Reinsch","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.15537\/1658-3175.3827","article-title":"Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression","volume":"28","author":"Sayyah-Melli","year":"2007","journal-title":"Saudi Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD000547.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.15537\/1658-3175.4796","article-title":"Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth","volume":"30","author":"Sayyah-Melli","year":"2009","journal-title":"Saudi Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1074-3804(05)60254-X","article-title":"GnRH agonist treatment before total laparoscopic hysterectomy for large uteri","volume":"10","author":"Seracchioli","year":"2003","journal-title":"Journal of the American Association of Gynecologic Laparoscopists"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000547.pub3-BIB0039|cit39","first-page":"150","article-title":"Mechanism of LHRH analogue action in uterine fibroids","volume":"32","author":"Shaw","year":"1989","journal-title":"Hormone Research"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0040|cit40","unstructured":"Shaw RW Placebo controlled comparison of the effectiveness of the microparticles depot formulation of buserelin in the pre-operative management of patients with uterine fibroids Clinical\/biometric report, Hoechst Marion Roussel, UK Ltd"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD000547.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/0002-9378(91)91419-W","article-title":"A randomised trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas","volume":"164","author":"Stovall","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/S0002-9378(94)70350-7","article-title":"Gonadotropin-releasing hormone agonist use before hysterectomy","volume":"170","author":"Stovall","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0029-7844(95)00102-W","article-title":"GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial","volume":"86","author":"Stovall","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD000547.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.1998.tb09967.x","article-title":"Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial","volume":"105","author":"Vercellini","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0015-0282(03)00362-5","article-title":"Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial","volume":"79","author":"Vercellini","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-2115(99)00168-2","article-title":"Leuporelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial","volume":"89","author":"Verspyck","year":"2000","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive BIology"},{"issue":"12","key":"10.1002\/14651858.CD000547.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2008-1104","article-title":"Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy","volume":"93","author":"Wilkens","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1696\u20131704","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata","volume":"22","author":"Williams","year":"2007","journal-title":"Human Reproduction"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD000547.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0002-9378(98)70635-0","article-title":"A prospective randomised study to evaluate leuprolide acetate treatment before laparascopic myomectomy: efficacy and ultrasonographic predictors","volume":"178","author":"Zullo","year":"1998","journal-title":"American Journal of Obstetetrics and Gynecology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0050|cit50","unstructured":"Zullo F Pellicano M Di Carlo C De Stefano R Mastrantonio P Nappi C GnRH-a pretreatment and laparoscopic intramural myomectomy: efficacy and ultrasonographic correlations (abstract) American Society for Reproductive Medicine 1996 S134"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/01443615.2014.896884","article-title":"Experience with a gonadotropin-releasing hormone agonist prior to myomectomy - comparison of twice- vs thrice-monthly doses and a control group","volume":"34","author":"Bassaw","year":"2014","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD000547.pub3-BIB0052|cit52","first-page":"119","article-title":"Progesterone preoperative treatment before myomectomy with the Intrauterine Bigatti Shaver (IBS)","volume":"11","author":"Bigatti","year":"2014","journal-title":"Gynecological Surgery"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejogrb.2015.06.018","article-title":"Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study","volume":"192","author":"Bizzarri","year":"2015","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000547.pub3-BIB0054|cit54","first-page":"i467","article-title":"Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas","volume":"31","author":"Bondi","year":"2016","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.fertnstert.2008.02.128","article-title":"Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial","volume":"91","author":"Coddington","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jsgi.2006.02.008","article-title":"Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor","volume":"13","author":"De Falco","year":"2006","journal-title":"Journal of the Society for Gynecologic Investigation"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.steroids.2004.10.008","article-title":"Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern","volume":"70","author":"Di Lieto","year":"2005","journal-title":"Steroids"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long term treatment of uterine fibroids with ulipristal acetate","volume":"10","author":"Donnez","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejogrb.2013.03.007","article-title":"Does medical debulking with gonadotropin-releasing hormone agonist facilitate vaginal hysterectomy with a moderate enlarged uterus? A randomised controlled study","volume":"169","author":"Elzaher","year":"2013","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jmig.2015.12.002","article-title":"Ulipristal acetate before high complexity hysteroscopic myomectomy: a retrospective comparative study","volume":"23","author":"Ferrero","year":"2016","journal-title":"Journal of Minimally Invasive Gynecology"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD000547.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.jmig.2016.08.672","article-title":"Ulipristal acetate versus triptorelin prior to laparoscopic myomectomy: prospective study","volume":"23","author":"Ferrero","year":"2016","journal-title":"Journal of Minimally Invasive Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jmu.2014.05.001","article-title":"Color Doppler misoprostol response study (CDMRS): an evaluation tool for patients awaiting myomectomy","volume":"22","author":"Hasan","year":"2014","journal-title":"Journal of Medical Ultrasound"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000547.pub3-BIB0063|cit63","first-page":"50","article-title":"The preoperative treatment of women with myoma of the uterus using ulipristal acetate","volume":"32","author":"Hutsikava","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/09513590400021029","article-title":"Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy","volume":"20","author":"Mizutani","year":"2005","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0065|cit65","first-page":"289","article-title":"The study of the effect of presurgical GnRH agonist treatment for women with uterine leiomyoma - effect on the myoma volume and the operation","volume":"43","author":"Nakano","year":"1998","journal-title":"Japanese Journal of Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-0282(00)01676-9","article-title":"Effectiveness of short term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy","volume":"75","author":"Palomba","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A randomised controlled clinical trial comparing the effects of aromatase inhibitor (letrazole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"Parsanezhad","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD000547.pub3-BIB0068|cit68","first-page":"499","article-title":"Clinical use of leuprolide acetate depot in a group of gynecologic patients in the preoperative period","volume":"50","author":"Russo","year":"1998","journal-title":"Minerva Ginecologica"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0029-7844(95)00191-S","article-title":"Leuprolide acetate treatment and myoma arterial size","volume":"86","author":"Rutgers","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"07","key":"10.1002\/14651858.CD000547.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.21474\/IJAR01\/17351","article-title":"Ulipristal acetate versus placebo for fibroid treatment","volume":"11","author":"Shipika","year":"2023","journal-title":"International Journal of Advanced Research"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/j.fertnstert.2016.08.005","article-title":"First US-based phase 3 study of ulipristal acetate (UPA) for symptomatic uterine fibroids (UF): results of VENUS-1","volume":"106","author":"Simon","year":"2016","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0072|cit72","first-page":"1372","article-title":"Effects of a single rectal dose of Misoprostol prior to abdominal hysterectomy in women with symptomatic leiomyoma: a randomised double blind clinical trial","volume":"7","author":"Tabatabai","year":"2015","journal-title":"Electronic Physician"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.fertnstert.2005.09.034","article-title":"Gestrinone versus danazol as preoperative treatment for hysteroscopic surgery: a prospective randomised evaluation","volume":"85","author":"Triolo","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1471-0528.2000.tb13226.x","article-title":"A double-blind randomised trial of leuprorelin acetate prior to hysterectomy for dysfunctional uterine bleeding","volume":"107","author":"Duffy","year":"2000","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9378(99)70140-7","article-title":"Uterine ultrasonographic changes with gondatrophin-releasing hormone agonists","volume":"180","author":"Weeks","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0076|cit76","first-page":"1470","article-title":"Decrease in symptoms, blood loss and uterine size with nafarelin acetate before abdominal hysterectomy: a placebo-controlled, double-blind study","volume":"10","author":"Ylikorkala","year":"1995","journal-title":"Human Reproduction"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD000547.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1471-0528.1992.tb13534.x","article-title":"Fibroids: overview of current and future treatment options","volume":"99","author":"Benagiano","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0078|cit78","first-page":"658","article-title":"Using analogous preoperative Gn-RH in the treatment of symptomatic uterine leiomyomatosis","volume":"11","author":"Gambardella","year":"1995","journal-title":"Giornarle Italiano di Ostetrica e Ginecologica"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0079|cit79","first-page":"72","article-title":"Clinical outcome of pretreatment with mifepristone before laparoscopic myomectomy","volume":"82","author":"Sun","year":"2021","journal-title":"Indian Journal of Pharmaceutical Sciences"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13063-024-07923-2","article-title":"The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial","volume":"25","author":"Kawahara","year":"2024","journal-title":"Trials"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13063-024-08170-1","article-title":"The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study)","volume":"25","author":"Kitade","year":"2024","journal-title":"Trials"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-0037-1607264","article-title":"Uterine fibroids: burden and unmet medical need","volume":"35","author":"Al-Hendy","year":"2017","journal-title":"Seminars in Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD000547.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.0001-6349.2005.00690.x","article-title":"Short term and long term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women","volume":"84","author":"Campo","year":"2005","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"7","key":"10.1002\/14651858.CD000547.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/jwh.2008.0456","article-title":"What are the total costs of surgical treatment for uterine fibroids?","volume":"17","author":"Carls","year":"2008","journal-title":"Journal of Women's Health"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jmig.2011.02.010","article-title":"Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomised controlled trials","volume":"18","author":"Chen","year":"2011","journal-title":"Journal of Minimally Invasive Gynecology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"1003605","DOI":"10.3389\/fmed.2022.1003605","article-title":"Global, regional, and national burden of uterine fibroids in the last 30 years: estimates from the 1990 to 2019 Global Burden of Disease Study","volume":"9","author":"Cheng","year":"2022","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0088|cit88","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","author":"Deeks","year":"2023"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Human Reproduction Update"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.fertnstert.2020.07.028","article-title":"Fibroids and medical therapy: bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist","volume":"114","author":"Donnez","year":"2020","journal-title":"Fertility and Sterility"},{"issue":"400 (10356)","key":"10.1002\/14651858.CD000547.pub3-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(22)01475-1.","article-title":"Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials","volume":"17","author":"Donnez","year":"2022","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0092|cit92","unstructured":"Ulipristal-acetate-uterine-fibroids https:\/\/www.ema.europa.eu\/en\/documents\/referral\/ulipristal-acetate-5mg-medicinal-products-article-31-referral-ulipristal-acetate-uterine-fibroids_en.pdf."},{"issue":"4 Part 1","key":"10.1002\/14651858.CD000547.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0002-9378(90)90667-V","article-title":"Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotrophin-releasing hormone agonists: the estrogen window hypothesis","volume":"163","author":"Friedman","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0094|cit94","first-page":"405","volume-title":"Ultrasound in Obstetrics and Gynecology","author":"Geirsson","year":"1993"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0096|cit96","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"e0149631","DOI":"10.1371\/journal.pone.0149631","article-title":"Medical therapies for uterine fibroids - a systematic review and network meta-analysis of randomised controlled trials","volume":"11","author":"Gurusamy","year":"2016","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0098|cit98","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajog.2010.02.039","article-title":"Racial and ethnic disparities in benign gynecologic conditions and associated surgeries","volume":"202","author":"Jacoby","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fertnstert.2003.06.009","article-title":"Raloxifene prevents the growth of uterine leiomyomas in premenopausal women","volume":"81","author":"Jirecek","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0301-2115(96)02416-5","article-title":"Treatment of fibromas","volume":"66","author":"Jourdain","year":"1996","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejogrb.2014.03.009","article-title":"Use of GnRH analogues preoperatively for hysteroscopic resection of submucous fibroids: a systematic review and metaanalysis","volume":"177","author":"Kamath","year":"2014","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"8","key":"10.1002\/14651858.CD000547.pub3-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005355.pub5","article-title":"Interventions to reduce haemorrhage during myomectomy for fibroids","author":"Kongnyuy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0104|cit104","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated October 2023). Cochrane, 2023 Available from https:\/\/training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0105|cit105","unstructured":"Li T Higgins JPT Deeks JJ Chapter 5: Collecting data [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1471-0528.1989.tb01663.x","article-title":"Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin","volume":"96","author":"Matta","year":"1989","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0107|cit107","first-page":"CR24","article-title":"Hysterectomy surveillance in the United States, 1997 to 2005","volume":"14","author":"Merrill","year":"2008","journal-title":"Medical Science Monitor"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0108|cit108","unstructured":"Medicines & Healthcare Products Regulatory Agency (MHRA) https:\/\/www.gov.uk\/government\/organisations\/medicines-and-healthcare-products-regulatory-agency"},{"issue":"7","key":"10.1002\/14651858.CD000547.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/bcp.14708","article-title":"Risk-efficacy balance of ulipristal acetate compared to surgical alternatives","volume":"87","author":"Bet","year":"2021","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/humrep\/deac009","article-title":"Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids","volume":"37","author":"Middelkoop","year":"2022","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010854.pub2","article-title":"Add-back therapy with GnRH analogues for uterine fibroids","author":"Moroni","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2014.01.022","article-title":"The cost effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids","volume":"175","author":"Nagy","year":"2014","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"9","key":"10.1002\/14651858.CD000547.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/humrep\/13.9.2592","article-title":"Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: literature review","volume":"13","author":"Parazzini","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.fertnstert.2014.07.008","article-title":"Alternative therapies in management of leiomyomas","volume":"102","author":"Patel","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0015-0282(16)55790-2","article-title":"Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study","volume":"59","author":"Perino","year":"1993","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.maturitas.2014.06.002","article-title":"EMAS position statement: management of uterine fibroids","volume":"79","author":"P\u00e9rez-L\u00f3pez","year":"2014","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0117|cit117","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000547.pub3-BIB0118|cit118","first-page":"134","article-title":"Rationale for the short-term use of luteinising hormone-releasing hormone analogues in the treatment of uterine myomata","volume":"32","author":"Stovall","year":"1989","journal-title":"Hormone Research"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD000547.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/0002-9378(91)91419-W","article-title":"A randomized trial evaluating leuprolide acetate before hysterectomy as a treatment for leiomyomas","volume":"164","author":"Stovall","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD000547.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00016348509155136","article-title":"Comparison of cellular levels of steroid receptors in uterine leiomyomas and myometrium","volume":"64","author":"Tamaya","year":"1985","journal-title":"Acta Obstetricia et Gynaecologica Scandinavica"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"101995","DOI":"10.1016\/j.eclinm.2023.101995","article-title":"Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial","volume":"60","author":"Whitaker","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1002\/14651858.CD000547.pub3-BIB0122|cit122","first-page":"647","volume-title":"Te Linde's Operative Gynaecology","author":"Wallach","year":"1992"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD000547.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1471-0528.1992.tb13536.x","article-title":"Goserelin (Zoladex) in the treatment of fibroids","volume":"99","author":"West","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"International Journal of Gynecological Pathology"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0125|cit125","first-page":"20","article-title":"Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissue","volume":"55","author":"Wilson","year":"1980","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD000547.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.fertnstert.2011.01.142","article-title":"Impact of submucous fibroid on the severity of anemia","volume":"95","author":"Yang","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD000547.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"591.e1","DOI":"10.1016\/j.ajog.2018.09.039","article-title":"A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014","volume":"219","author":"Yu","year":"2018","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000547.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/13696998.2016.1254090","article-title":"Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in the Netherlands: cost minimisation analysis and budget impact analysis","volume":"20","author":"Zakiyah","year":"2017","journal-title":"Journal of Medical Economics"},{"issue":"2","key":"10.1002\/14651858.CD000547.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/OGX.0000000000000036","article-title":"The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a metaanalysis","volume":"69","author":"Zhang","year":"2014","journal-title":"Obstetrical & Gynecological Survey"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000547.pub3-BIB0131|cit131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD000547.pub3-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000547.pub2","article-title":"Preoperative medical therapy before surgery for uterine fibroids","author":"Vollenhoven","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:20:43Z","timestamp":1790583643000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000547.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":132,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000547.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}